Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Plos One
|
June 5, 2012
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice
Thomas Lundåsen, Eva-Marie Andersson, Michael Snaith, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
March 1, 2020
A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings
Veronika Voronova, Victor Sokolov, Amani Al-Khaifi, et al.
Journal of Internal Medicine
|
April 24, 2014
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Bo Angelin, Jens D Kristensen, Mats Eriksson, et al.
Plos One
|
February 12, 2016
Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans
Mikael Lehtihet, Ylva Bonde, Lena Beckman, et al.
Circulation
|
August 28, 2002
Accumulation of foam cells in liver X receptor-deficient mice
Gertrud U Schuster, Paolo Parini, Ling Wang, et al.
Cell Metabolism
|
August 6, 2008
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man
Cecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov, et al.
The New England Journal of Medicine
|
March 12, 2010
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia
Paul W Ladenson, Jens D Kristensen, E Chester Ridgway, et al.
Cell Metabolism
|
February 12, 2013
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist
Sama I Sayin, Annika Wahlström, Jenny Felin, et al.
Clinical Chemistry
|
June 9, 2012
Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration
Jason S Troutt, Mats Rudling, Lena Persson, et al.
European Journal of Clinical Investigation
|
November 19, 2016
High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia
Miguel A Frias, Aurélien Thomas, Marie-Claude Brulhart-Meynet, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Plos One
|
June 5, 2012
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice
Thomas Lundåsen, Eva-Marie Andersson, Michael Snaith, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
March 1, 2020
A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings
Veronika Voronova, Victor Sokolov, Amani Al-Khaifi, et al.
Journal of Internal Medicine
|
April 24, 2014
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Bo Angelin, Jens D Kristensen, Mats Eriksson, et al.
Plos One
|
February 12, 2016
Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans
Mikael Lehtihet, Ylva Bonde, Lena Beckman, et al.
Circulation
|
August 28, 2002
Accumulation of foam cells in liver X receptor-deficient mice
Gertrud U Schuster, Paolo Parini, Ling Wang, et al.
Cell Metabolism
|
August 6, 2008
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man
Cecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov, et al.
The New England Journal of Medicine
|
March 12, 2010
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia
Paul W Ladenson, Jens D Kristensen, E Chester Ridgway, et al.
Cell Metabolism
|
February 12, 2013
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist
Sama I Sayin, Annika Wahlström, Jenny Felin, et al.
Clinical Chemistry
|
June 9, 2012
Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration
Jason S Troutt, Mats Rudling, Lena Persson, et al.
European Journal of Clinical Investigation
|
November 19, 2016
High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia
Miguel A Frias, Aurélien Thomas, Marie-Claude Brulhart-Meynet, et al.
Page
of 7